Posthuma de Boer J - Search Results

1

The Clay Shoveler's Fracture: A Case Report and Review of the Literature.

Posthuma de Boer J, van Wulfften Palthe AF, Stadhouder A, Bloemers FW. Posthuma de Boer J, et al. J Emerg Med. 2016 Sep;51(3):292-7. doi: 10.1016/j.jemermed.2016.03.020. Epub 2016 Jun 1. J Emerg Med. 2016. PMID: 27262733 Review.

2

Small cell osteosarcoma of a toe phalanx: a case report and review of literature.

Posthumadeboer J, Graat HC, Bras J, Saouti R. Posthumadeboer J, et al. J Orthop Surg Res. 2010 Jun 3;5:36. doi: 10.1186/1749-799X-5-36. J Orthop Surg Res. 2010. PMID: 20525255 Free PMC article.

3

Synovial Chondromatosis of the Midcarpal Joint: A Case Report and Brief Review of Literature.

PosthumaDeBoer J, Torrekens M, Nuffel MV. PosthumaDeBoer J, et al. J Wrist Surg. 2021 Mar 24;11(2):177-180. doi: 10.1055/s-0041-1726405. eCollection 2022 Apr. J Wrist Surg. 2021. PMID: 35478946 Free PMC article.

4

Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.

PosthumaDeBoer J, Witlox MA, Kaspers GJ, van Royen BJ. PosthumaDeBoer J, et al. Clin Exp Metastasis. 2011 Jun;28(5):493-503. doi: 10.1007/s10585-011-9384-x. Epub 2011 Apr 2. Clin Exp Metastasis. 2011. PMID: 21461590 Free PMC article. Review.

5

Pelvic reconstruction with a free vascularized distal femur for revision total hip arthroplasty.

Van de Kerkhove MP, PosthumaDeBoer J, Jiya TU, Winters HA, Saouti R. Van de Kerkhove MP, et al. J Arthroplasty. 2012 Mar;27(3):493.e19-22. doi: 10.1016/j.arth.2011.03.049. Epub 2011 Jul 1. J Arthroplasty. 2012. PMID: 21723694

6

Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.

Posthumadeboer J, van Egmond PW, Helder MN, de Menezes RX, Cleton-Jansen AM, Beliën JA, Verheul HM, van Royen BJ, Kaspers GJ, van Beusechem VW. Posthumadeboer J, et al. Oncotarget. 2012 Oct;3(10):1169-81. doi: 10.18632/oncotarget.600. Oncotarget. 2012. PMID: 23045411 Free PMC article.

7

Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.

Posthumadeboer J, Piersma SR, Pham TV, van Egmond PW, Knol JC, Cleton-Jansen AM, van Geer MA, van Beusechem VW, Kaspers GJ, van Royen BJ, Jiménez CR, Helder MN. Posthumadeboer J, et al. Br J Cancer. 2013 Oct 15;109(8):2142-54. doi: 10.1038/bjc.2013.578. Epub 2013 Sep 24. Br J Cancer. 2013. PMID: 24064975 Free PMC article.

8

WEE1 inhibition sensitizes osteosarcoma to radiotherapy.

PosthumaDeBoer J, Würdinger T, Graat HC, van Beusechem VW, Helder MN, van Royen BJ, Kaspers GJ. PosthumaDeBoer J, et al. BMC Cancer. 2011 Apr 29;11:156. doi: 10.1186/1471-2407-11-156. BMC Cancer. 2011. PMID: 21529352 Free PMC article.

9

Long-term clinical outcome of collagenase clostridium histolyticum treatment is independent of Dupuytren Diathesis Score.

VAN Nuffel M, Posthuma DE Boer J, Cootjans K, Borgers A, DE Smet L, Degreef I. VAN Nuffel M, et al. Among authors: posthuma de boer j. Acta Orthop Belg. 2023 Jun;89(2):233-240. doi: 10.52628/89.2.11781. Acta Orthop Belg. 2023. PMID: 37924539

10

Phase-field method for epitaxial kinetics on surfaces.

Posthuma de Boer J, Ford IJ, Kantorovich L, Vvedensky DD. Posthuma de Boer J, et al. J Chem Phys. 2018 Nov 21;149(19):194107. doi: 10.1063/1.5049548. J Chem Phys. 2018. PMID: 30466263 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page